Covered recipient · General Payments record
NICOLE E YAMAGIWA
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,207.68
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $912.56 | 26 |
| Education | $32.27 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $458.90 | 11 |
| Amgen Inc. | $182.61 | 5 |
| Lilly USA, LLC | $151.85 | 3 |
| PFIZER INC. | $66.39 | 3 |
| Exact Sciences Corporation | $21.01 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $20.50 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.68 | 1 |
| ABBVIE INC. | $14.60 | 1 |
| Acerta Pharma LLC | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.60 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108445709 | CMS |
| Amgen Inc. | $26.25 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117419938 | CMS |
| Amgen Inc. | $122.58 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117419940 | CMS |
| Amgen Inc. | $5.36 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117722814 | CMS |
| Amgen Inc. | $13.73 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117722816 | CMS |
| Amgen Inc. | $14.69 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117722818 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.29 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104472310 | CMS |
| Exact Sciences Corporation | $21.01 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114451124 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $20.50 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146785186 | CMS |
| Lilly USA, LLC | $119.93 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135919104 | CMS |
| Lilly USA, LLC | $9.43 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135913567 | CMS |
| Lilly USA, LLC | $22.49 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135906784 | CMS |
| Novo Nordisk Inc | $19.44 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100400935 | CMS |
| Novo Nordisk Inc | $24.61 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100329938 | CMS |
| Novo Nordisk Inc | $22.03 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100299839 | CMS |
| Novo Nordisk Inc | $32.27 | 04/25/2024 | Education | Undisputed | 01/23/2026 | 1100230164 | CMS |
| Novo Nordisk Inc | $125.00 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100313485 | CMS |
| Novo Nordisk Inc | $22.97 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100369757 | CMS |
| Novo Nordisk Inc | $25.00 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100262526 | CMS |
| Novo Nordisk Inc | $124.26 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100292924 | CMS |
| Novo Nordisk Inc | $20.58 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100546594 | CMS |
| Novo Nordisk Inc | $19.86 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100538960 | CMS |
| Novo Nordisk Inc | $22.88 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100542198 | CMS |
| PFIZER INC. | $20.49 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130997655 | CMS |
| PFIZER INC. | $25.27 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131455580 | CMS |
| PFIZER INC. | $20.63 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132094520 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.68 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137847476 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.